Wallet

That Ol’ Share-of-Wallet Issue

NeuGroup’s Assistant Treasurers’ Leadership Group tackles managing banks and the corporate wallet.

stock market ticker62

Libor to SOFR Switch Will Be Challenging

Response to CME’s SOFR futures contracts may provide early signal.

NGI Skyline

Get the Latest Insights

Sign up to have an eye in the room where it happens. Connect to NeuGroup Insights 
here.

Cash & Working Capital

Incredible Hulk-Bruce Banner Nature of Life Sciences

Share |
August 14, 2019

Treasurers grapple with capital allocation issues as cash flows wax and wane with drug approvals, expiring patents and other ups and downs.

There’s nothing like dramatic stock price moves to illustrate the feast or famine nature of revenue and cash flow at life sciences companies, which live or die by the success or failure of clinical trials for drugs and devices.
iTreasurer subscribers please log in below
 
 
 
Forgot your password?
Click here to request a new one.
 
Want to change your password?
Click here to change it.